Quarterly report pursuant to Section 13 or 15(d)

Consolidated Balance Sheets (Unaudited)

v3.23.1
Consolidated Balance Sheets (Unaudited) - USD ($)
Mar. 31, 2023
Dec. 31, 2022
Current assets    
Cash $ 11,911,219 $ 13,468,026
Non-current assets    
Acquired patents, net 8,100 9,003
Total assets 11,919,319 13,477,029
Current liabilities    
Accounts payable & accrued interest 220,845 220,845
Unreimbursed expenses 14,730 42,060
Total current liabilities 235,575 262,905
Total liabilities 235,575 262,905
Stockholders’ equity    
Common stock, $0.001 par value; 100,000,000 shares authorized; 12,848,165 shares issued and outstanding as of March 31, 2023 and December 31, 2022 12,848 12,848
Additional paid-in capital 55,268,564 54,674,042
Accumulated deficit (43,597,668) (41,472,766)
Total stockholders’ equity 11,683,744 13,214,124
Total liabilities and stockholders’ equity $ 11,919,319 $ 13,477,029